Theravance Biopharma, Inc. (TBPH)
13.93
+0.15
(+1.09%)
USD |
NASDAQ |
Mar 16, 16:00
13.91
-0.02
(-0.14%)
Pre-Market: 08:43
Theravance Biopharma Total Liabilities (Quarterly) : 182.78M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Integer Holdings Corp. | 1.664B |
| QuidelOrtho Corp. | 3.849B |
| Nektar Therapeutics | 190.57M |
| Innoviva, Inc. | 462.32M |
| CorMedix, Inc. | 472.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 415.46M |
| Shareholders Equity (Quarterly) | 232.68M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |